Morgan Stanley’s Genetic Technologies Ltd. GENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-19,389
| Closed | -$15K | – | 8242 |
|
|
2024
Q3 | $15K | Buy |
19,389
+1,400
| +8% | +$1.25K | ﹤0.01% | 6596 |
|
|
2024
Q2 | $27K | Buy |
17,989
+500
| +3% | +$1.13K | ﹤0.01% | 6366 |
|
|
2024
Q1 | $50.5K | Sell |
17,489
-17,089
| -49% | -$39.3K | ﹤0.01% | 6210 |
|
|
2023
Q4 | $83K | Buy |
34,578
+17,047
| +97% | +$56.5K | ﹤0.01% | 6222 |
|
|
2023
Q3 | $66.8K | Sell |
17,531
-140
| -0.8% | -$571 | ﹤0.01% | 6046 |
|
|
2023
Q2 | $73.4K | Sell |
17,671
-2,745
| -13% | -$13.6K | ﹤0.01% | 6068 |
|
|
2023
Q1 | $118K | Buy |
20,416
+10,380
| +103% | +$60.8K | ﹤0.01% | 5942 |
|
|
2022
Q4 | $46.7K | Sell |
10,036
-430
| -4% | -$2.44K | ﹤0.01% | 6323 |
|
|
2022
Q3 | $62K | Sell |
10,466
-40
| -0.4% | -$292 | ﹤0.01% | 6310 |
|
|
2022
Q2 | $61K | Buy |
10,506
+5,080
| +94% | +$36.7K | ﹤0.01% | 6522 |
|
|
2022
Q1 | $54K | Sell |
5,426
-6,498
| -54% | -$63.1K | ﹤0.01% | 6672 |
|
|
2021
Q4 | $112K | Buy |
11,924
+5,901
| +98% | +$75.6K | ﹤0.01% | 6373 |
|
|
2021
Q3 | $93K | Sell |
6,023
-6,296
| -51% | -$108K | ﹤0.01% | 6425 |
|
|
2021
Q2 | $261K | Buy |
12,319
+11,829
| +2,414% | +$239K | ﹤0.01% | 5877 |
|
|
2021
Q1 | $10K | Buy |
490
+230
| +88% | +$5.26K | ﹤0.01% | 6953 |
|
|
2020
Q4 | $5K | Sell |
260
-1,829
| -88% | -$30.2K | ﹤0.01% | 6780 |
|
|
2020
Q3 | $36K | Buy |
2,089
+1,090
| +109% | +$20.3K | ﹤0.01% | 5841 |
|
|
2020
Q2 | $11K | Buy |
+999
| New | +$10.2K | ﹤0.01% | 6145 |
|
|
2019
Q3 | – | Sell |
-1
| Closed | – | – | 6807 |
|
|
2019
Q2 | $0 | Buy |
+1
| New | +$15 | ﹤0.01% | 6790 |
|
|
2019
Q1 | – | Sell |
-76
| Closed | -$1K | – | 6753 |
|
|
2018
Q4 | $1K | Hold |
76
| – | – | ﹤0.01% | 6536 |
|
|
2018
Q3 | $2K | Hold |
76
| – | – | ﹤0.01% | 6591 |
|
|
2018
Q2 | $2K | Hold |
76
| – | – | ﹤0.01% | 6565 |
|
|
2018
Q1 | $2K | Hold |
76
| – | – | ﹤0.01% | 6510 |
|
|
2017
Q4 | $2K | Buy |
76
+1
| +1% | +$19 | ﹤0.01% | 6456 |
|
|
2017
Q3 | $1K | Hold |
75
| – | – | ﹤0.01% | 6478 |
|
|
2017
Q2 | $1K | Hold |
75
| – | – | ﹤0.01% | 6533 |
|
|
2017
Q1 | $2K | Hold |
75
| – | – | ﹤0.01% | 6468 |
|
|
2016
Q4 | $2K | Buy |
75
+25
| +50% | +$693 | ﹤0.01% | 6391 |
|
|
2016
Q3 | $2K | Hold |
50
| – | – | ﹤0.01% | 6377 |
|
|
2016
Q2 | $2K | Sell |
50
-274
| -85% | -$12.6K | ﹤0.01% | 6373 |
|
|
2016
Q1 | $15K | Sell |
324
-561
| -63% | -$24.4K | ﹤0.01% | 6022 |
|
|
2015
Q4 | $47K | Buy |
885
+668
| +308% | +$33.7K | ﹤0.01% | 5742 |
|
|
2015
Q3 | $8K | Sell |
217
-51
| -19% | -$2.74K | ﹤0.01% | 6302 |
|
|
2015
Q2 | $16K | Buy |
268
+127
| +90% | +$10.6K | ﹤0.01% | 6192 |
|
|
2015
Q1 | $15K | Buy |
+141
| New | +$11.5K | ﹤0.01% | 6134 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 6698 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 6683 |
|
|
2014
Q2 | – | Sell |
-271
| Closed | -$32.4K | – | 6622 |
|
|
2014
Q1 | $38K | Buy |
+271
| New | +$43.4K | ﹤0.01% | 5807 |
|
Other funds holding GENE
Morgan Stanley's GENE Position: Q4 2024 in Review
Morgan Stanley sold out of Genetic Technologies Ltd. (GENE) in Q4 2024, closing a stake of 19,389 shares — an estimated $15K sold.
Morgan Stanley first reported a position in GENE in Q1 2014 and held it in 36 quarters. The position peaked at $261K in Q2 2021. 1 fund tracked by Wall St. Rank holds GENE as of Q4 2024.
- Morgan Stanley reported no remaining Genetic Technologies Ltd. position as of Q4 2024 after selling out during the quarter.
- Morgan Stanley sold 19,389 Genetic Technologies Ltd. shares in Q4 2024, an estimated $15K.
- Morgan Stanley first reported a position in Genetic Technologies Ltd. in Q1 2014 and held it in 36 quarters.
- Morgan Stanley's Genetic Technologies Ltd. position peaked at $261K in Q2 2021.
- 1 fund tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q4 2024.
Based on Morgan Stanley's 13F filing for Q4 2024, filed 14 Feb 2025.